NCR1 and leukemia: This association protected NK from the downregulation of activating-receptor expression (more particularly NKp46/NCR1) induced by leukemia cells; thus, it enhanced NK cytotoxicity and tumor immune control with significant improvement in leukemia-free survival [59].